...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Differential modulation of brainstem phosphatidylinositol 3-kinase/akt and extracellular signal-regulated kinase 1/2 signaling underlies WIN55,212-2 centrally mediated pressor response in conscious rats
【24h】

Differential modulation of brainstem phosphatidylinositol 3-kinase/akt and extracellular signal-regulated kinase 1/2 signaling underlies WIN55,212-2 centrally mediated pressor response in conscious rats

机译:脑干磷脂酰肌醇3-激酶/ akt和细胞外信号调节激酶1/2信号的差异调节奠定了清醒大鼠WIN55,212-2中央介导的升压反应的基础

获取原文
获取原文并翻译 | 示例
           

摘要

Our recent study demonstrated that central cannabinoid receptor 1 (CB 1R) activation caused dose-related pressor response in conscious rats, and reported studies implicated the brainstem phosphatidylinositol 3-kinase (PI3K)/Akt-extracellular signal-regulated kinase 1/2 (ERK1/2) pathway in blood pressure control. Therefore, in this study, we tested the hypothesis that the modulation of brainstem PI3K/Akt-ERK1/2 signaling plays a critical role in the central CB 1R-mediated pressor response. In conscious freely moving rats, the pressor response elicited by intracisternal (i.c.) (R)-(+)-[2,3-dihydro- 5-methyl-3[(4-morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4- benzoxazinyl]-(1-naphthalenyl) methanone mesylate salt (WIN55,212-2) (15 μg) was associated with significant increases in ERK1/2 phosphorylation in the rostral ventrolateral medulla (RVLM) and the nucleus tractus solitarius (NTS). In contrast, Akt phosphorylation was significantly reduced in the same neuronal pools. Pretreatment with the selective CB 1R antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)- 4-methyl-1H- pyrazole-3-carboxamide (AM251) (30 μg i.c.) attenuated the neurochemical responses elicited by central CB 1R activation. Furthermore, pretreatment with the ERK/mitogenactivated protein kinase kinase inhibitor 2′-amino-3′-methoxyflavone (PD98059) (5 μg i.c.) abrogated WIN55,212-2-evoked increases in blood pressure and neuronal ERK1/2 phosphorylation but not the reduction in Akt phosphorylation. On the other hand, prior PI3K inhibition with wortmannin (0.4μg i.c.) exacerbated the WIN55,212-2 (7.5 and 15 μg i.c.) dose-related increases in blood pressure and ERK1/2 phosphorylation in the RVLM. The present neurochemical and integrative studies yield new insight into the critical role of two brainstem kinases, PI3K and ERK1/2, in the pressor response elicited by central CB 1R activation in conscious rats.
机译:我们最近的研究表明,中枢大麻素受体1(CB 1R)的激活引起了清醒大鼠的剂量相关升压反应,并且报道的研究涉及脑干磷脂酰肌醇3-激酶(PI3K)/ Akt-细胞外信号调节激酶1/2(ERK1) / 2)血压控制途径。因此,在这项研究中,我们测试了脑干PI3K / Akt-ERK1 / 2信号传导的调节在中枢CB 1R介导的升压反应中起关键作用的假设。在有意识的自由运动大鼠中,脑池内(ic)(R)-(+)-[2,3-二氢-5-甲基-3 [(4-吗啉基)甲基]吡咯并[1,2,3]引起的升压反应-de] -1,4-苯并恶嗪基]-(1-萘基)甲磺酸甲磺酸盐(WIN55,212-2)(15μg)与头侧腹外侧延髓(RVLM)和ERK1 / 2磷酸化显着相关孤束核(NTS)。相反,在相同的神经元库中,Akt磷酸化明显降低。用选择性CB 1R拮抗剂N-(哌啶-1-基)-5-(4-碘苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺(AM251)进行预处理( 30μgic)减弱了中央CB 1R激活引起的神经化学反应。此外,用ERK /促分裂原活化蛋白激酶激酶抑制剂2'-氨基-3'-甲氧基黄酮(PD98059)(5μgic)进行的预处理消除了WIN55,212-2-引起的血压升高和神经元ERK1 / 2磷酸化,但没有减少Akt磷酸化。另一方面,先前用渥曼青霉素(0.4μgi.c.)对PI3K的抑制加剧了RV55中血压和ERK1 / 2磷酸化的剂量相关的WIN55,212-2(7.5和15μgi.c.)的增加。目前的神经化学和综合性研究对有意识的大鼠中枢CB 1R活化引起的升压反应中两种脑干激酶PI3K和ERK1 / 2的关键作用产生了新的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号